| Q39396195 | A 12-month evaluation of the CMA-containing oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties |
| Q34114548 | A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). |
| Q44086641 | A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women |
| Q43726031 | A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment |
| Q82444270 | Acne and hormonal contraceptives |
| Q33811508 | Acne and rosacea. New and emerging therapies |
| Q38322319 | Acne in women |
| Q40132397 | Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line |
| Q39084169 | Chemical pharmacotherapy options for managing adult acne |
| Q33643621 | Clinician/patient interaction: communicating the benefits and risks of oral contraceptives |
| Q24201998 | Combined oral contraceptive pills for treatment of acne |
| Q24202713 | Combined oral contraceptive pills for treatment of acne |
| Q24240056 | Combined oral contraceptive pills for treatment of acne |
| Q24246230 | Combined oral contraceptive pills for treatment of acne |
| Q34920073 | Contraceptive needs of the perimenopausal woman |
| Q33921867 | Contraceptive strategies for young women in the 21st century |
| Q35167201 | Controversies in adolescent hormonal contraception |
| Q35187362 | Current concepts of the pathogenesis of acne: implications for drug treatment |
| Q57311816 | Dermatotherapeutic Agents |
| Q36605428 | Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome |
| Q41724983 | Effect of low-dose oral contraceptives on androgenic markers and acne. |
| Q52182475 | Effectiveness of oral contraceptives in the treatment of acne. |
| Q34271948 | Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne |
| Q42994099 | Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact |
| Q34636056 | European evidence-based (S3) guidelines for the treatment of acne. |
| Q38049608 | Harnessing the power of crowds: crowdsourcing as a novel research method for evaluation of acne treatments |
| Q34089756 | Health benefits of oral contraceptives |
| Q34706886 | Hormonal therapies in acne |
| Q34129807 | Hormonal therapy in dermatology |
| Q34074139 | Hormonal treatment of acne in women |
| Q34667697 | Is hormonal treatment still an option in acne today? |
| Q36520694 | Management of acne: Canadian clinical practice guideline. |
| Q33938125 | Management strategies for acne vulgaris |
| Q34003456 | Managing acne in adolescents |
| Q38875492 | Molecular action of norgestimate: new developments |
| Q34821475 | Noncontraceptive health benefits of oral contraceptives |
| Q33643613 | Oral contraceptive health benefits: perception versus reality |
| Q34798259 | Oral contraceptives as anti-androgenic treatment of acne |
| Q34082121 | Perimenstrual flare of adult acne |
| Q36573746 | Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills |
| Q53081474 | Porcine intestinal lymphoid tissues synthesize estradiol. |
| Q37169658 | Practical considerations in acne treatment and the clinical impact of topical combination therapy |
| Q37672179 | Profiling and hormonal therapy for acne in women |
| Q55053646 | Retrospective, observational study on the effects and tolerability of flutamide in a large population of patients with acne and seborrhea over a 15-year period. |
| Q33715142 | Spironolactone for the treatment of acne in women, a retrospective study of 110 patients |
| Q44192904 | The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne |
| Q32140007 | The emerging use of the 20-microg oral contraceptive |
| Q35902342 | The role of combined oral contraceptives in the management of acne and seborrhea |
| Q37808207 | Therapeutic Considerations for Severe Nodular Acne |
| Q33992214 | Treating acne. A practical guide |
| Q73260204 | Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence |
| Q79788910 | [New contraceptives] |